MEDS
Undervalued by 64.9% based on the discounted cash flow analysis.
Market cap | $8.75 Million |
---|---|
Enterprise Value | $15.70 Million |
Dividend Yield | $0.0 (0.0%) |
Earnings per Share | $-7.49 |
Beta | 0.0 |
Outstanding Shares | 1,406,348 |
Avg 30 Day Volume | 22,194 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -0.49 |
---|---|
PEG | -0.04 |
Price to Sales | 1.18 |
Price to Book Ratio | - |
Enterprise Value to Revenue | 1.9 |
Enterprise Value to EBIT | -2.16 |
Enterprise Value to Net Income | -1 |
Total Debt to Enterprise | 0.45 |
Debt to Equity | 13.1 |
No data
No data